Standout Papers

Long-Term Efficacy, Survival, and Safety of [177Lu-DOTA0,Tyr3]octreotate in Patients with Gastroentero... 2017 2026 2020 2023 401
  1. Long-Term Efficacy, Survival, and Safety of [177Lu-DOTA0,Tyr3]octreotate in Patients with Gastroenteropancreatic and Bronchial Neuroendocrine Tumors (2017)
    Tessa Brabander, Wouter A. van der Zwan et al. Clinical Cancer Research

Immediate Impact

1 from Science/Nature 56 standout
Sub-graph 1 of 20

Citing Papers

Aromatic side-chain crosslinking in RiPP biosynthesis
2025 Standout
GPCR drug discovery: new agents, targets and indications
2025 Standout
2 intermediate papers

Works of Tessa Brabander being referenced

Long-Term Efficacy, Survival, and Safety of [177Lu-DOTA0,Tyr3]octreotate in Patients with Gastroenteropancreatic and Bronchial Neuroendocrine Tumors
2017 Standout
Pitfalls in the response evaluation after peptide receptor radionuclide therapy with [177Lu-DOTA0,Tyr3]octreotate
2017

Author Peers

Author Last Decade Papers Cites
Tessa Brabander 936 1015 350 770 53 1.4k
Stefano Severi 1067 1087 391 806 57 1.5k
D. J. Kwekkeboom 716 981 426 539 33 1.5k
Amir Kurtaran 663 754 512 394 62 1.6k
Vincenzo Allegri 382 420 404 312 31 1.1k
Raffaella Barone 753 891 782 523 22 1.4k
Viktor Johanson 533 610 211 439 43 994
Stefan Guhlke 867 699 812 484 51 1.5k
Sabine Haufe 433 491 661 315 31 1.5k
H. Bihl 336 396 530 365 58 1.2k
Dariusz Pawlak 643 633 688 416 61 1.3k

All Works

Loading papers...

Rankless by CCL
2026